Literature DB >> 28321897

Statistical reporting of clinical pharmacology research.

Arne Ring1,2, Robert Schall1,3, Yoon K Loke4, Simon Day5.   

Abstract

Research in clinical pharmacology covers a wide range of experiments, trials and investigations: clinical trials, systematic reviews and meta-analyses of drug usage after market approval, the investigation of pharmacokinetic-pharmacodynamic relationships, the search for mechanisms of action or for potential signals for efficacy and safety using biomarkers. Often these investigations are exploratory in nature, which has implications for the way the data should be analysed and presented. Here we summarize some of the statistical issues that are of particular importance in clinical pharmacology research.
© 2017 The British Pharmacological Society.

Keywords:  clinical pharmacology; confirmatory statistics; exploratory statistics; meta-analyses; randomized clinical trials

Mesh:

Year:  2017        PMID: 28321897      PMCID: PMC5427231          DOI: 10.1111/bcp.13254

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Why are pharmacokinetic data summarized by arithmetic means?

Authors:  S A Julious; C A Debarnot
Journal:  J Biopharm Stat       Date:  2000-02       Impact factor: 1.051

2.  The empirical coverage of confidence intervals: point estimates and confidence intervals for confidence levels.

Authors:  Robert Schall
Journal:  Biom J       Date:  2012-05-23       Impact factor: 2.207

3.  Statistical guide for clinical pharmacology & therapeutics.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2010-06-30       Impact factor: 6.875

Review 4.  Learning versus confirming in clinical drug development.

Authors:  L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1997-03       Impact factor: 6.875

5.  Statistical reporting of clinical pharmacology research.

Authors:  Arne Ring; Robert Schall; Yoon K Loke; Simon Day
Journal:  Br J Clin Pharmacol       Date:  2017-03-21       Impact factor: 4.335

6.  Common misconceptions about data analysis and statistics.

Authors:  Harvey J Motulsky
Journal:  Br J Pharmacol       Date:  2014-09-26       Impact factor: 8.739

7.  A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 study.

Authors:  Arne Ring; Tom Morris; Marcin Wozniak; Nikol Sullo; William Dott; Veerle Verheyden; Tracy Kumar; Nigel Brunskill; Rakesh Vaja; Gavin J Murphy
Journal:  Br J Clin Pharmacol       Date:  2016-12-01       Impact factor: 4.335

8.  Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-04-17

9.  To test or not to test: Preliminary assessment of normality when comparing two independent samples.

Authors:  Justine Rochon; Matthias Gondan; Meinhard Kieser
Journal:  BMC Med Res Methodol       Date:  2012-06-19       Impact factor: 4.615

Review 10.  An investigation of the false discovery rate and the misinterpretation of p-values.

Authors:  David Colquhoun
Journal:  R Soc Open Sci       Date:  2014-11-19       Impact factor: 2.963

  10 in total
  4 in total

1.  Warfarin dose requirement in patients having severe thrombosis or thrombophilia.

Authors:  Tuukka A Helin; Lotta Joutsi-Korhonen; Heidi Asmundela; Mikko Niemi; Arto Orpana; Riitta Lassila
Journal:  Br J Clin Pharmacol       Date:  2019-06-17       Impact factor: 4.335

2.  Statistical reporting of clinical pharmacology research.

Authors:  Arne Ring; Robert Schall; Yoon K Loke; Simon Day
Journal:  Br J Clin Pharmacol       Date:  2017-03-21       Impact factor: 4.335

3.  Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomized controlled VaSera trial.

Authors:  Luca Faconti; Charlotte Elizabeth Mills; Virginia Govoni; Haotian Gu; Steven Morant; Benju Jiang; J Kennedy Cruickshank; Andrew James Webb
Journal:  Br J Clin Pharmacol       Date:  2018-11-13       Impact factor: 4.335

4.  Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study.

Authors:  Keso Skhirtladze-Dworschak; Doris Hutschala; Georg Reining; Peter Dittrich; Anna Bartunek; Martin Dworschak; Edda M Tschernko
Journal:  Br J Clin Pharmacol       Date:  2019-02-13       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.